MSF viewpoint proposes integrating monoclonal antibodies and vaccines as post-exposure prophylaxis for Ebola outbreak control (scienceportal.msf.org)

• MSF advocates for targeted use of PEP with monoclonal antibodies and vaccines.
• PEP could interrupt transmission chains and limit Ebola spread.
• Flexible deployment and rapid logistics are needed for PEP in outbreak settings.

"A viewpoint by Médecins Sans Frontières (MSF) proposes integrating monoclonal antibodies and vaccines as post-exposure prophylaxis (PEP) to enhance Ebola outbreak control. The article argues that targeted PEP, administered to contacts, can interrupt transmission chains and reduce virus spread. MSF emphasizes the need for flexible deployment strategies and rapid logistics to maximize effectiveness in outbreak settings."